North Crest Asset Manangement, LLC Abbott Laboratories Transaction History

North Crest Asset Manangement, LLC

$4.13 Billion
Q4 2025

A detailed history of North Crest Asset Manangement, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 59,482 shares of ABT stock, worth $7.73 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

59,482

Previous 67,693 12.13%

Holding current value

$7.73 Million

Previous $9.07 Million 14.69%

% of portfolio

0.19%

Previous 0.23%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	SELL	$123.62 - $134.59 $1.02 Million - $1.11 Million	-8,211 Reduced 12.13%	59,482 $7.73 Million
Q3 2025 Oct 29, 2025	BUY	$120.51 - $136.62 $15,907 - $18,033	132 Added 0.2%	67,693 $9.07 Million
Q2 2025 Jul 10, 2025	BUY	$123.95 - $138.08 $596,075 - $664,026	4,809 Added 7.66%	67,561 $9.19 Million
Q1 2025 Apr 16, 2025	BUY	$111.1 - $140.22 $3,444 - $4,346	31 Added 0.05%	62,752 $8.32 Million
Q4 2024 Mar 17, 2025	SELL	$111.93 - $119.39 $175,730 - $187,442	-1,570 Reduced 2.44%	62,721 $7.09 Million

Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $47,233 - $55,757	472 Added 0.74%	64,291 $7.33 Million
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $95,089 - $106,143	944 Added 1.5%	63,819 $6.63 Million
Q1 2024 Apr 15, 2024	BUY	$109.52 - $120.96 $31,541 - $34,836	288 Added 0.46%	62,875 $7.15 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $77,653 - $95,054	-861 Reduced 1.36%	62,587 $6.89 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $23,213 - $27,852	-243 Reduced 0.38%	63,448 $6.14 Million
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $81,027 - $90,281	804 Added 1.28%	63,691 $6.94 Million
Q1 2023 Apr 25, 2023	BUY	$96.86 - $114.01 $1.4 Million - $1.64 Million	14,423 Added 29.76%	62,887 $6.37 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $1.07 Million - $1.26 Million	-11,270 Reduced 18.87%	48,464 $5.32 Million
Q3 2022 Oct 17, 2022	BUY	$96.76 - $112.03 $42,380 - $49,069	438 Added 0.74%	59,734 $5.78 Million
Q2 2022 Jul 18, 2022	BUY	$102.07 - $123.37 $1.61 Million - $1.95 Million	15,789 Added 36.29%	59,296 $6.44 Million
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $1.57 Million - $1.92 Million	-13,803 Reduced 24.08%	43,507 $5.15 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $6.62 Million - $8.11 Million	57,310 New	57,310 $8.07 Million

Others Institutions Holding ABT

# of Institutions

3,638

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.

Account

North Crest Asset Manangement, LLC Abbott Laboratories Transaction History